Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
28,590,514
-
Share change
-
-521,992
-
Total reported value
-
$118,082,334
-
Put/Call ratio
-
158%
-
Price per share
-
$4.13
-
Number of holders
-
119
-
Value change
-
-$3,301,322
-
Number of buys
-
53
-
Number of sells
-
50
Institutional Holders of INOVIO PHARMACEUTICALS INC - COM NEW (INO) as of Q4 2017
As of 31 Dec 2017,
INOVIO PHARMACEUTICALS INC - COM NEW (INO) was held by
119 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,590,514 shares.
The largest 10 holders included
BlackRock Inc., STATE STREET CORP, Vanguard Group Inc, WASATCH ADVISORS INC, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, PANAGORA ASSET MANAGEMENT INC, DEUTSCHE BANK AG\, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
119
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.